Naomi Aronson, PhD, is Executive Director of Clinical Evaluation, Innovation, and Policy, Blue Cross and Blue Shield Association (BCBSA). Dr. Aronson leads BCBSA clinical effectiveness and policy engagement with government, regulatory agencies and policy consortia. Her areas of leadership include comparative effectiveness, patient centered research, safety surveillance, regulatory science and methodological standards. Previously, Dr. Aronson led the development of the BCBSA Technology Evaluation Center (TEC) as a nationally recognized technology assessment program and an Evidence-based Practice Center (EPC) of the Agency for Healthcare Research and Quality (AHRQ). Dr. Aronson is a member of the Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Dr. Aronson is a member of the Health Technology Assessment International Health Policy Forum, the National Academies of Sciences Genomics Roundtable, and the National Business Group on Health Committee on Evidence-Based Benefit Design. Prior to joining TEC, Dr. Aronson was a member of the Northwestern University faculty, specializing in the sociology of science and medicine. She also was a post-doctoral fellow in the Science, Technology and Society Program at the Massachusetts Institute of Technology.
Conflict of Interest Disclosures
As of February 1, 2019
Financial or Business Associations:
- None reported.
- EXCITE International, Board Officer
- Clinical Trial Transformation Initiative, Member
- National Academy of Medicine, Member
- Health Technology Assessment International, Member
- Tapestry Networks, Committee/Work Group member